The most common adverse reaction from omalizumab is injection site in duration, injection site itching, injection site pain and bruising but the package insert contains warnings regarding parasitic infections. While there are no reports of fatal anaphylaxis as a result of omalizumab, some cases have been serious and potentially life-threatening. Therefore, the FDA requires that people receiving omalizumab be monitored in the physician's office for a period of time after their injections.
Biotechnological ideas are getting bigger and bigger nowadays. As more and more innovator/inventor choose treatment as convenient way of therapy, biologic agents and other facilities valuable methods must be discovered in order to cope with a growing number of biological agents. This special issue emphasize on new generation monoclonal humanized antibodies in asthmatics [1][2][3].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.